17 studies found for:    Anticonvulsants | Open Studies | Chicago
Show Display Options
Rank Status Study
1 Recruiting Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Conditions: Epilepsy;   Pregnancy
Intervention:
2 Recruiting Lacosamide for Seizure Prophylaxis in High-Grade Gliomas
Condition: Brain Cancer
Interventions: Drug: Lacosamide;   Other: Placebo
3 Recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Conditions: Epilepsy;   Lennox-Gastaut Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
4 Recruiting Once Daily Gabapentin in the Treatment of Post Amputation Pain
Conditions: Pain;   Quality of Life
Intervention: Drug: Gralise
5 Recruiting Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
6 Recruiting A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
Condition: Partial Onset Seizures
Interventions: Drug: Pregabalin Dose Level 1;   Drug: Pregabalin Dose Level 2;   Drug: Placebo
7 Recruiting A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
Conditions: Epilepsy, Partial Seizures;   Epilepsy, Primary Generalized Tonic-Clonic Seizures
Intervention: Drug: Pregabalin
8 Recruiting Pregnant Women Taking Lamictal for Bipolar Disorder
Condition: Bipolar Disorder
Intervention: Drug: lamotrigine
9 Recruiting Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide;   Drug: Placebo
10 Not yet recruiting The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
Condition: Depression, Postpartum
Intervention: Drug: Magnesium Sulfate
11 Recruiting Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
Condition: Painful Diabetic Peripheral Neuropathy (PDPN)
Interventions: Drug: ASP3662;   Drug: pregabalin;   Drug: ASP3662 placebo;   Drug: pregabalin placebo
12 Recruiting Treatment of Pain Associated With Fibromyalgia
Condition: Pain Associated With Fibromyalgia
Interventions: Drug: DS-5565 15mg tablet;   Drug: 150mg pregabalin capsule;   Drug: placebo tablet;   Drug: placebo capsule;   Drug: 75mg pregabalin capsule
13 Recruiting Treatment of Pain Associated With Fibromyalgia
Condition: Pain Associated With Fibromyalgia
Interventions: Drug: DS-5565 15mg tablet;   Drug: 150mg pregabalin capsule;   Drug: placebo tablet;   Drug: placebo capsule;   Drug: 75mg pregabalin capsule
14 Recruiting A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate (FF);   Drug: vilanterol (VI);   Drug: umeclidinium bromide (UMEC)
15 Recruiting Treatment of Pain Associated With Fibromyalgia
Condition: Pain Associated With Fibromyalgia
Interventions: Drug: DS-5565 15mg tablet;   Drug: 150mg pregabalin capsule;   Drug: placebo tablet;   Drug: placebo capsule;   Drug: 75mg pregabalin capsule
16 Recruiting Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Conditions: Idiopathic Parkinson's Disease;   Drug Induced Dyskinesia
Intervention: Drug: Topiramate
17 Recruiting Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Condition: Cervical Spondylotic Myelopathy
Interventions: Drug: riluzole;   Drug: Placebo medication

Indicates status has not been verified in more than two years